Previous 10 | Next 10 |
It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...
Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire SAN CARLOS, Calif. , Jan. 5, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced t...
U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent SAN CARLOS, Calif. , Dec. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Paten...
Increased adoption and expansion of products resulting in significant rises in volume. Producing meaningful improvements in revenues and costs per unit. Confidently raising 2020 guidance. For further details see: Natera: Conceive, Deliver, Thrive
New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial SAN CARLOS, Calif. , Dec. 9, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that n...
Natera to Present New Immunotherapy Monitoring Data at SABCS 2020 SAN CARLOS, Calif. , Dec. 8, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and ...
Natera (NTRA) announces that the second-largest U.S. commercial insurer has extended coverage of non-invasive prenatal tests ((NIPT)) to all singleton pregnancies. The largest player announced the same several days ago.The expanded coverage bodes well for the company's Panorama molecular test...
Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies SAN CARLOS, Calif. , Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest...
Natera (NTRA) says that the largest health plan in the United States has extended coverage of Non-Invasive Prenatal Testing ((NIPT)) to all pregnancies.The expanded coverage comes only a few months after the publication of recent studies has shown support for offering aneuploidy scr...
Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies PR Newswire SAN CARLOS, Calif., Dec. 1, 2020 SAN CARLOS, Calif. , Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...